| Literature DB >> 27754331 |
Yan-Lun Ju1, Min Liu2, Hui Zhao3, Jiang-Fei Meng4, Yu-Lin Fang5,6.
Abstract
The anthocyanin composition, fatty acids, and volatile aromas are important for Cabernet Sauvignon grape quality. This study evaluated the effect of exogenous abscisic acid (ABA) and methyl jasmonate (MeJA) on the anthocyanin composition, fatty acids, lipoxygenase activity, and the volatile compounds of Cabernet Sauvignon grape berries. Exogenous ABA and MeJA improved the content of total anthocyanins (TAC) and individual anthocyanins. Lipoxygenase (LOX) activity also increased after treatment. Furthermore, 16 fatty acids were detected. The linoleic acid concentration gradually increased with ABA concentration. The fatty acid content decreased with increasing MeJA concentration and then increased again, with the exception of linoleic acid. After exogenous ABA and MeJA treatment, the C6 aroma content increased significantly. Interestingly, the exogenous ABA and MeJA treatments improved mainly the content of 1-hexanol, hexanal, and 2-heptanol. These results provide insight into the effect of plant hormones on wine grapes, which is useful for grape quality improvement.Entities:
Keywords: Cabernet Sauvignon; physicochemical; plant hormones; volatile aroma
Mesh:
Substances:
Year: 2016 PMID: 27754331 PMCID: PMC6273220 DOI: 10.3390/molecules21101354
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Physico-chemical properties of Cabernet Sauvignon berries with different treatments.
| Variable | ABA | MeJA | C | ||||
|---|---|---|---|---|---|---|---|
| A1 | A2 | A3 | J1 | J2 | J3 | ||
| Brix | 21.83 ± 0.12 a | 21.97 ± 0.12 a | 22.17 ± 0.06 a | 21.03 ± 0.40 a | 22.03 ± 0.06 b | 21.23 ± 0.08 a | 21.13 ± 0.29 a |
| pH | 3.95 ± 0.03 a | 4.01 ± 0.01 a | 3.92 ± 0.01 a | 3.82 ± 0.02 b | 3.94 ± 0.01 a | 3.91 ± 0.03 a | 3.97 ± 0.01 a |
| Total Acid (g L−1) | 3.65 ± 0.03 a | 3.57 ± 0.06 a | 3.47 ± 0.04 b | 3.66 ± 0.05 a | 3.67 ± 0.30 a | 4.07 ± 0.06 c | 3.49 ± 0.01 b |
| TPC (mg·g−1) | 21.18 ± 0.28 b | 20.29 ± 0.24 c | 19.18 ± 0.06 d | 22.19 ± 0.05 b | 21.93 ± 0.10 c | 19.18 ± 0.06 c | 18.19 ± 0.28 a |
| TAC (mg·g−1) | 12.28 ± 0.34 b | 10.53 ± 0.08 c | 9.81 ± 0.32 d | 9.82 ± 0.10 b | 9.56 ± 0.03 b | 9.60 ± 0.15 b | 8.85 ± 0.09 a |
Note: Values are the mean of three replicates (±standard deviation). A1: treatment with 1000 mg·L−1 ABA; A2: treatment with 600 mg·L−1 ABA; A3: treatment with 200 mg·L−1 ABA; J1: treatment with 800 µmol·L−1 MeJA; J2: treatment with 200 µmol·L−1 MeJA; J3: treatment with 50 µmol·L−1 MeJA; C: control. Different letters within a column indicate statistically significant differences between the means (p < 0.05).
Individual anthocyanin content of Cabernet Sauvignon berry skins after different treatments (mean ± SD, n = 3, mg·L−1).
| Treatments | Delphinidin-3- | Cyanidin-3- | Petunidin-3- | Peonidin-3- | Malvidin-3- | Non-Acylated (%) | Peonidin-3- | Malvidin-3- | Acetyl Derivatives (%) | Peonidin-3- | Malvidin-3- | Coumaryl Derivatives (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C | 171.68 ± 3.91 a | 40.32 ± 0.78 a | 100.47 ± 2.35 a | 107.88 ± 2.45 a | 565.77 ± 12.98 a | 72.29 | 30.90 ± 0.59 a | 266.09 ± 6.75 ab | 21.77 | 13.29 ± 0.67 a | 67.70 ± 3.34 a | 5.94 |
| J1 | 130.17 ± 3.19 b | 23.70 ± 0.50 b | 88.63 ± 2.54 b | 110.32 ± 3.35 a | 678.66 ± 19.14 b | 68.50 | 30.44 ± 1.05 a | 334.56 ± 12.19 d | 24.24 | 13.32 ± 0.33 a | 96.03 ± 3.25 d | 7.26 |
| J2 | 177.82 ± 5.55 a | 38.06 ± 0.66 a | 107.52 ± 3.85 ac | 109.53 ± 3.39 a | 617.42 ± 26.11 a | 71.16 | 30.71 ± 1.16 a | 298.41 ± 14.08 c | 22.30 | 14.22 ± 0.83 a | 82.27 ± 4.98 c | 6.54 |
| J3 | 189.55 ± 9.34 a | 49.12 ± 5.89 c | 112.94 ± 5.61 cd | 146.90 ± 18.30 b | 617.04 ± 26.96 a | 72.64 | 40.89 ± 5.17 c | 288.86 ± 10.60 bc | 21.47 | 15.80 ± 1.60 a | 74.56 ± 2.76 abc | 5.88 |
| A1 | 217.68 ± 3.20 c | 61.94 ± 0.96 d | 123.55 ± 2.24 d | 138.56 ± 2.46 b | 589.32 ± 12.32 a | 73.50 | 37.94 ± 0.64 c | 284.51 ± 6.05 bc | 20.95 | 14.54 ± 0.24 a | 70.88 ± 1.64 ab | 5.55 |
| A2 | 216.52 ± 7.66 c | 62.60 ± 1.85 d | 123.03 ± 3.86 d | 158.81 ± 4.43 b | 597.93 ± 15.09 a | 75.48 | 37.77 ± 0.97 b | 248.15 ± 6.14 a | 18.62 | 18.74 ± 0.48 b | 71.82 ± 1.45 ab | 5.90 |
| A3 | 176.41 ± 14.54 a | 33.93 ± 7.04 a | 107.05 ± 8.31 ac | 105.55 ± 19.10 a | 608.18 ± 37.50 a | 71.16 | 30.22 ± 5.16 a | 296.49 ± 14.58 c | 22.55 | 13.44 ± 1.78 a | 77.76 ± 3.91 bc | 6.29 |
Notes: A1: treatment with 1000 mg·L−1 ABA; A2: treatment with 600 mg·L−1 ABA; A3: treatment with 200 mg·L−1 ABA; J1: treatment with 800 µmol·L−1 MeJA; J2: treatment with 200 µmol·L−1 MeJA; J3: treatment with 50 µmol·L−1 MeJA; C: control. Different letters within a column indicate statistically significant differences between the means (p < 0.05).
Figure 1Heat map of anthocyanins and volatile aromas after different treatments. A1: treatment with 1000 mg·L−1 ABA; A2: treatment with 600 mg·L−1 ABA; A3: treatment with 200 mg·L−1 ABA; J1: treatment with 800 µmol·L−1 MeJA; J2: treatment with 200 µmol·L−1 MeJA; J3: treatment with 50 µmol·L−1 MeJA; C: control. Values are the mean of three replicates (±standard deviation). The heat map graphic distances were measured using Euclidean distances, and the clustering algorithm using ward dendrogram. Each colored cell on the map corresponds to a concentration value (normalized to the control sample).
Fatty acid composition in Cabernet Sauvignon berries after different treatments (mean ± SD, n = 3, mg·Kg−1).
| Fatty acid | C | A1 | A2 | A3 | J1 | J2 | J3 |
|---|---|---|---|---|---|---|---|
| linoleic acid | 138.23 ± 7.92 a | 116.75 ± 8.40 b | 178.08 ± 5.30 c | 147.3 ± 9.23 d | 127.32 ± 8.35 e | 136.72 ± 3.26 a | 120.49 ± 5.24 b |
| elaidic acid | 72.22 ± 7.22 a | 90.02 ± 5.37 b | 102.75 ± 3.42 c | 124.70 ± 6.29 d | 109.12 ± 7.39 cd | 104.33 ± 0.28 c | 104.44 ± 6.27 c |
| 9-hexadecenoic acid | 0.61 ± 0.052 a | 1.16 ± 0.058 b | 1.15 ± 0.082 b | 0.89 ± 0.032 c | 1.09 ± 0.069 d | 0.89 ± 0.072 c | 1.05 ± 0.127 d |
| hexadecanoic acid | 126.67 ± 9.03 a | 146.72 ± 7.93 b | 187.36 ± 8.19 c | 164.58 ± 5.09 d | 159.26 ± 5.83 e | 147.43 ± 6.83 b | 193.17 ± 5.23 ce |
| stearic acid | 15.34 ± 1.14 a | 20.02 ± 1.62 b | 21.00 ± 1.78 bc | 21.88 ± 1.29 bc | 21.02 ± 1.42 bc | 15.84 ± 1.52 a | 28.21 ± 1.37 d |
| docosanoic acid | 7.17 ± 0.51 a | 11.99 ± 0.38 b | 10.99 ± 0.69 bc | 10.66 ± 0.59 bc | 13.27 ± 0.61 d | 7.53 ± 0.26 a | 15.89 ± 0.39 d |
| eicosanoic acid | 3.40 ± 0.21 a | 5.07 ± 0.26 b | 4.55 ± 0.19 c | 5.42 ± 0.32 de | 5.29 ± 0.33 e | 4.21 ± 0.31 c | 3.18 ± 0.19 a |
| PUFA | 211.06 ± 8.92 a | 207.93 ± 7.98 a | 281.98 ± 10.61 b | 272.89 ± 9.45 c | 237.53 ± 6.98 d | 241.94 ± 7.46 d | 225.98 ± 7.34 e |
| MUFA | 152.58 ± 7.23 a | 183.8 ± 8.79 b | 223.9 ± 7.84 c | 202.54 ± 10.54 bc | 198.84 ± 9.57 c | 175.01 ± 7.98 d | 240.45 ± 7.21 e |
Notes: A1: treatment with 1000 mg·L−1 ABA; A2: treatment with 600 mg·L−1 ABA; A3: treatment with 200 mg·L−1 ABA; J1: treatment with 800 µmol·L−1 MeJA; J2: treatment with 200 µmol·L−1 MeJA; J3: treatment with 50 µmol·L−1 MeJA; C, Control. PUFA, polyunsaturated fatty acid; MUFA, monounsaturated fatty acid. Different letters within a column indicate statistically significant differences between the means (p < 0.05).
Figure 2Lipoxygenase activity of Cabernet Sauvignon berries after different treatments. (A) ABA treatment; (B) MeJA treatment. Experiments were repeated three times. Data are the mean ± SD of replicates. ABA1000: treatment with 1000 mg·L−1 ABA; ABA600: treatment with 600 mg·L−1 ABA; ABA200: treatment with 200 mg·L−1 ABA; MeJA800: treatment with 800 µmol·L−1 MeJA; MeJA200: treatment with 200 µmol·L−1 MeJA; MeJA50: treatment with 50 µmol·L−1 MeJA; C: control. Different letters within a column indicate statistically significant differences between the means (p < 0.05).
Figure 3Important features identified by PLS-DA. Partial Least Squares-Discriminant Analysis (PLS-DA) model was built between the data (X) and the permuted class labels (Y) using the optimal number of components determined by cross validation for the model based on the original class assignment. Variable Importance in Projection (VIP) is a weighted sum of squares of the PLS loadings taking into account the amount of explained Y-variation in each dimension. VIP scores are calculated for each component. The colored boxes on the right indicate the relative concentration of the corresponding metabolites in each group under study. A1: treatment with 1000 mg·L−1 ABA; A2: treatment with 600 mg·L−1 ABA; A3: treatment with 200 mg·L−1 ABA; J1: treatment with 800 µmol·L−1 MeJA; J2: treatment with 200 µmol·L−1 MeJA; J3: treatment with 50 µmol·L−1 MeJA; C: control. Values are the mean of three replicates.
Figure 4PCA scores plot of samples after different treatments. The colored dots represent samples from different treatments. Seven independent treatment studies, each with triplicate samples, were used in the analysis. A1: treatment with 1000 mg·L−1 ABA; A2: treatment with 600 mg·L−1 ABA; A3: treatment with 200 mg·L−1 ABA; J1: treatment with 800 µmol·L−1 MeJA; J2: treatment with 200 µmol·L−1 MeJA; J3: treatment with 50 µmol·L−1 MeJA; C: control.